NAB-PACLIEVA 100 MG
Paclitaxel (Protein Bound Particles) for Injection Suspension 100 MG
NAB-PACLIEVA 100 MG (Paclitaxel Protein-Bound Particles for Injection Suspension 100 mg) is a prescription anticancer medicine containing Paclitaxel 100 mg formulated as albumin-bound (protein-bound) nanoparticles for intravenous administration. This advanced formulation is designed to improve the delivery of Paclitaxel to tumor tissues while eliminating the need for certain solvent-based excipients used in conventional paclitaxel formulations. Paclitaxel belongs to a class of medicines known as Taxane Antineoplastic Agents, which work by interfering with the normal function of microtubules inside cancer cells. By stabilizing microtubules and preventing their breakdown, Paclitaxel inhibits cell division and ultimately leads to cancer cell death. NAB-PACLIEVA 100 MG is widely used in the treatment of several cancers, including breast cancer, non-small cell lung cancer (NSCLC), and pancreatic cancer. It may be administered alone or in combination with other anticancer medicines depending on the treatment protocol and patient condition. The albumin-bound technology enhances drug transport and allows effective chemotherapy delivery without the need for certain solvent-related premedications commonly required with conventional Paclitaxel formulations. NAB-PACLIEVA 100 MG is commonly prescribed for: Metastatic Breast Cancer Advanced Breast Cancer Non-Small Cell Lung Cancer (NSCLC) Metastatic Pancreatic Cancer Locally Advanced Pancreatic Cancer Combination Chemotherapy Programs Oncology Treatment Protocols Advanced Solid Tumors Manufactured according to stringent pharmaceutical quality standards, NAB-PACLIEVA 100 MG is designed to provide consistent quality, safety, and therapeutic effectiveness. Patients receiving treatment require regular monitoring of blood counts, liver function, and overall health status throughout therapy. Due to its proven efficacy and innovative formulation, NAB-PACLIEVA 100 MG remains an important option in modern oncology treatment.
View Details